A summary of the reported use of JAK inhibitors to treat cutaneous and systemic sarcoidosis.

Name: A summary of the reported use of JAK inhibitors to treat cutaneous and systemic sarcoidosis.
Creator: Ronan Talty
Published: 2021-08-11T06:13:10.803Z
Keywords: Dermatology, Sarcoidosis, Janus Kinase

Talty, Ronan; Damsky, William; King, Brett

doi:10.17632/jknxdjmm7b.1

A summary of the reported use of JAK inhibitors to treat cutaneous and systemic sarcoidosis.

Published: 11 August 2021| Version 1 | DOI: 10.17632/jknxdjmm7b.1

Contributors:

Ronan Talty, William Damsky, Brett King

Description

A summary of the reported use of JAK inhibitors to treat cutaneous and systemic sarcoidosis. CR – complete response; NCR – near complete response; PR – partial response.

A summary of the reported use of JAK inhibitors to treat cutaneous and systemic sarcoidosis.

Description

Files

Categories

Licence